Oscar Health Quarterly Income Statement
NYSE: OSCRHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Oscar Health revenue and earnings
In the quarter ended Jun 30, 2026, Oscar Health generated $4.88 billion in revenue, up 70.4% from the same quarter a year earlier. Net income was $361.8 million, for a net margin of 7.4% versus a median of -4.6% in the prior 5 quarters. Operating margin was 8.0%.
Diluted earnings per share came in at $1.10.
Summary generated from market data by MetaCap's automated system. Methodology
Oscar Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.88B | 4.65B | 2.81B | 2.99B | 2.86B | 3.05B | 2.39B | 2.42B | 2.22B | 2.14B | 1.43B | 1.44B |
| Revenue growth (YoY) | +70.40% | +52.55% | +17.25% | +23.21% | +29.04% | +42.20% | +67.11% | +68.30% | +45.86% | +45.77% | +43.87% | +47.17% |
| Operating Expenses | 4.49B | 3.94B | 3.14B | 3.12B | 3.09B | 2.75B | 2.54B | 2.47B | 2.15B | 1.96B | 1.58B | 1.50B |
| Selling, General & Admin | 691.08M | 706.23M | 511.03M | 521.59M | 534.49M | 482.76M | 465.82M | 460.38M | 435.21M | 394.16M | 364.15M | 325.85M |
| Operating Income | 388.63M | 704.09M | -333.75M | -129.25M | -230.48M | 297.12M | -147.73M | -48.37M | 67.81M | 185.56M | -145.48M | -58.24M |
| Interest Expense | 4.71M | 5.38M | -1.10M | 6.86M | 5.85M | 5.99M | 6.03M | 5.82M | 5.99M | 5.90M | 6.22M | 6.13M |
| Other Income (Expense) | -915.00K | 71.00K | -20.03M | -3.18M | 2.79M | -2.92M | 68.00K | 1.88M | -872.00K | -1.18M | 1.05M | -414.00K |
| Pretax Income | 383.01M | 698.77M | -352.68M | -139.29M | -233.54M | 288.21M | -153.69M | -52.31M | 60.95M | 178.48M | -150.64M | -64.79M |
| Income Tax | 21.18M | 19.75M | -247.00K | -1.81M | -5.04M | 12.71M | -404.00K | 2.08M | 4.64M | 996.00K | -806.00K | 915.00K |
| Net Income | 361.81M | 679.00M | -352.61M | -137.45M | -228.36M | 275.27M | -153.55M | -54.60M | 56.21M | 177.37M | -150.03M | -65.40M |
| Net Income growth (YoY) | — | +146.66% | — | — | -506.29% | +55.20% | — | — | — | — | — | — |
| EPS (Basic) | 1.20 | 2.28 | -1.37 | -0.53 | -0.89 | 1.10 | -0.68 | -0.22 | 0.24 | 0.77 | -0.68 | -0.29 |
| EPS (Diluted) | 1.10 | 2.07 | -1.19 | -0.53 | -0.89 | 0.92 | -0.50 | -0.22 | 0.20 | 0.62 | -0.68 | -0.29 |
| Shares Outstanding (Basic) | 302.22M | 298.18M | — | 259.27M | 255.53M | 251.28M | — | 243.11M | 238.67M | 231.44M | — | 223.10M |
| Shares Outstanding (Diluted) | 333.43M | 329.75M | — | 259.27M | 255.53M | 305.94M | — | 243.11M | 303.96M | 293.80M | — | 223.10M |
| EBITDA | 394.67M | 711.10M | -325.87M | -121.94M | -223.51M | 303.85M | -138.50M | -40.87M | 75.41M | 193.37M | -137.74M | -49.05M |
| Operating Margin | 7.96% | 15.15% | -11.90% | -4.33% | -8.05% | 9.75% | -6.17% | -2.00% | 3.06% | 8.66% | -10.16% | -4.04% |
| Net Margin | 7.41% | 14.61% | -12.57% | -4.60% | -7.97% | 9.04% | -6.42% | -2.25% | 2.53% | 8.28% | -10.48% | -4.54% |
This table shows 12 quarterly periods of Oscar Health's income statement, from Q2 2026 back to Q3 2023, across 16 line items including revenue, operating expenses, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow OSCR's reporting calendar. What is a income statement?